Search

Search Constraints

You searched for: Author/Creator Buti, Maria

Search Results

81. The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Issue 5 (11th October 2017)

82. The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Issue 5 (11th October 2017)

83. Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin. Issue 11 (4th October 2018)

84. Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end‐stage liver disease: Analysis of data from the Hepa‐C registry. Issue 6 (28th April 2017)

85. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study. Issue 3 (25th June 2020)

86. Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis. Issue 8 (4th September 2020)

87. Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis. Issue 5 (5th April 2012)